The platform's synthetic data capability will also reduce the need to use real patient data in many scenarios, supporting data safety and privacy.

Professor David Walliker, chief digital and information officer, MFT, said: ‘The launch of the ADAMS platform is about giving our clinicians and teams better access to the data they need to improve care for patients. By making it easier for approved users to access and analyse data, it will help us identify opportunities to improve quality, productivity and performance more quickly and support faster research and innovation.

‘The platform also strengthens our approach to data safety and privacy. ADAMS sits within MFT's existing governance framework, keeping data under NHS control and access limited to authorised users.

‘MFT already has a strong track record in digital innovation and data science. This platform builds on that foundation and will help us use data more effectively, support the safe development of AI, and ultimately improve care and outcomes for our patients.'